SALT LAKE CITY, May 21, 2019 /PRNewswire/ — Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to make a presentation at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019 at 3:30 am Eastern Time. This event is being held at the Grand Hyatt New York in New York City.
The company’s Chief Financial Officer, Clarence Verhoef, will provide an overview of Varex’s business and prospects. Varex’s presentation will be webcast and accessible to the public via the company’s website at vareximaging.com. Replays will be available for 90 days after the presentation at the same website.
About Varex Imaging
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 65+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose and protect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,000 people located at manufacturing and service center sites in North America, Europe, and Asia. For more information, visit vareximaging.com.
For Information Contact:
Howard Goldman
Director of Investor & Public Relations
Varex Imaging Corporation
801.978.5274 | howard.goldman@vareximaging.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/varex-to-present-at-the-jefferies-2019-healthcare-conference-300853792.html
SOURCE Varex Imaging Corporation
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…
Diarrhea is one of the most common reasons for veterinary visits for dogs and the…
Developing innovative bispecific antibodies for monotherapy and combination with the potential to expand the frontiers…
FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…